D’Indinosante, M.; Lardino, S.; Bruno, M.; Stabile, G.; Pavone, M.; Giannone, G.; Lombardi, P.; Daniele, G.; Fanfani, F.; Ciccarone, F.;
et al. Implications of Fumarate Hydratase Deficiency (FHD) and Cancer Risk: A Window into the Clinical and Oncological Implications of a Rare Disorder in Gynecology. Cancers 2025, 17, 573.
https://doi.org/10.3390/cancers17040573
AMA Style
D’Indinosante M, Lardino S, Bruno M, Stabile G, Pavone M, Giannone G, Lombardi P, Daniele G, Fanfani F, Ciccarone F,
et al. Implications of Fumarate Hydratase Deficiency (FHD) and Cancer Risk: A Window into the Clinical and Oncological Implications of a Rare Disorder in Gynecology. Cancers. 2025; 17(4):573.
https://doi.org/10.3390/cancers17040573
Chicago/Turabian Style
D’Indinosante, Marco, Sara Lardino, Matteo Bruno, Guglielmo Stabile, Matteo Pavone, Gaia Giannone, Pasquale Lombardi, Gennaro Daniele, Francesco Fanfani, Francesca Ciccarone,
and et al. 2025. "Implications of Fumarate Hydratase Deficiency (FHD) and Cancer Risk: A Window into the Clinical and Oncological Implications of a Rare Disorder in Gynecology" Cancers 17, no. 4: 573.
https://doi.org/10.3390/cancers17040573
APA Style
D’Indinosante, M., Lardino, S., Bruno, M., Stabile, G., Pavone, M., Giannone, G., Lombardi, P., Daniele, G., Fanfani, F., Ciccarone, F., & Scambia, G.
(2025). Implications of Fumarate Hydratase Deficiency (FHD) and Cancer Risk: A Window into the Clinical and Oncological Implications of a Rare Disorder in Gynecology. Cancers, 17(4), 573.
https://doi.org/10.3390/cancers17040573
